CD34 Positive Blood Cells for Allogeneic Progenitor and Stem Cell Transplantation

References

• Link H., Ehninger G., SchÖNrock-Nabulsi P., Gramatzki M., Daoud A., Tischler J., Brack N., Otremba B., Lutz M., GÄCkle R., ÖHl S., Heidemann E., Gieseler F., LÖFfler P., Weiss J., Geer T., Wandt H. Allogeneic bone marrow transplantation compared with high-dose ARA-C postremission therapy in acute myeloid leukemia. Bone Marrow Transplant 1996; 17: S100, Abstract)
   Google Scholar
• Löwenberg B. Post-remission treatment of acute myelogenous leukemia. New England Journal of Medicine 1995; 332: 260–262
   PubMed Web of Science ®Google Scholar
• Hoelzer D. Acute lymphoblastic leukemia—progress in children, less in adults. New Engl J Med 1993; 329: 1343–1344
   PubMed Web of Science ®Google Scholar
• Cavins J. A., Scheer S. C., Thomas E. D., Ferrebee J. W. The recovery of lethally irradiated dogs given infusions of autologous leukocytes preserved at -80 C. Blood 1964; 23: 38–43
   PubMed Web of Science ®Google Scholar
• Storb R., Epstein R. B., Ragde H., Bryant J., Thomas E. D. Marrow engraftment by allogeneic leukocytes in lethally irradiated dogs. Blood 1967; 30: 805–811
   PubMed Web of Science ®Google Scholar
• Fliedner T. M., Flad H. D., Bruch C., Calvo W., Goldmann S. F., Herbst E., Hugl E., Huget R., Korbling M., Krumbacher K., Nothdurft W., Ross W. M., Schnappauf H. P., Steinbach I. Treatment of aplastic anemia by blood stem cell transfusion: a canine model. Haematologica 1976; 61: 141–156
   PubMedGoogle Scholar
• Carbonell F., Calvo W., Fliedner T. M., Kratt E., Gerhartz H., KÖRbling M., Nothdurft W., Ross W. M. Cytogenetic studies in dogs after total body irradiation and allogeneic transfusion with cryopreserved blood mononuclear cells: observations in long-term chimeras. Int J Cell Cloning 1984; 2: 81–88
   PubMedGoogle Scholar
• Körbling M., DÖRken B., et al. Autologous transplantation of blood-derived hemopoietic stem cells after myeloab-lative therapy in a patient with Burkitt's lymphoma. Blood 1986; 67: 529–532
   PubMed Web of Science ®Google Scholar
• Hershko C., Gale R. P., Ho W. G., Cline M. J. Cure of aplastic anemia in paroxysmal nocturnal haemoglo-binuria by marrow transfusion from identical twin: failure of peripheral leukocyte transfusion to correct marrow aplasia. Lancet 1979; i: 945–947
   Google Scholar
• Abrams R. A., Glaubiger D., Appelbaum F. R., Deisseroth A. B. Result of attempted hematopoietic reconstitution using isologous peripheral blood mononuclear cells: a case report. Blood 1980; 56: 516–520
   PubMed Web of Science ®Google Scholar
• Gianni A. M., Siena S., Bregni M., Tarella C., Stern A. C., Pileri A., Bonadonna G. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 1989; 2: 580–585
   PubMed Web of Science ®Google Scholar
• Siena S., Bregni M., Brando B., Ravagnani F., Bonadonna G., Gianni A. M. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1989; 74: 1905–1914
   PubMed Web of Science ®Google Scholar
• Körbling M., Holle R., Haas R., Knauf W., Dorken B., Ho A. D., Kuse R., Pralle H., Fliedner T. M., Hunstein W. Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic site. J Clin Oncol 1990; 8: 978–985
   PubMed Web of Science ®Google Scholar
• Schmitz N., Linch D. C., Dreger P., Goldstone A. H., Boogaerts M. A., Ferrant A., Demuynck H. M. S., Link H., Zander A., Barge A., Borkett K. M. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 1996; 347: 353–357
   PubMed Web of Science ®Google Scholar
• Andrews R. G., Singer J. W., Bernstein I. D. Monoclonal antibody 12–8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 1986; 67: 842–845
   PubMed Web of Science ®Google Scholar
• Huang S., Terstappen L. W. Formation of haematopoietic microenvironment and haematopoietic stem cells from single human bone marrow stem cells. Nature 1992; 360: 745–749
   PubMed Web of Science ®Google Scholar
• Baum C. M., Weissman I. L., Tsukamoto A. S., Buckle A. M., Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci USA 1992; 89: 2804–2808
   PubMed Web of Science ®Google Scholar
• Krause D. S., Fackler M. J., Civin C. I., May W. S. CD34: structure, biology, and and clinical utility. Blood 1996; 87: 1–13
   PubMed Web of Science ®Google Scholar
• Terstappen L. W., Huang S., Safford M., Lansdorp P. M., Loken M. R. Sequential generations of hernatopoietic colonies derived from single nonlineage-com-mitted CD34+CD38– progenitor cells. Blood 1991; 77: 1218–1227
   PubMed Web of Science ®Google Scholar
• Berenson R. J., Andrews R. G., Bensinger W. I., Kalamasz D., Knitter G., Buckner C. D., Bernstein D. Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest 1988; 81: 951–955
   PubMed Web of Science ®Google Scholar
• Andrews R. G., Bryant E. M., Bartelmez S. H., Muirhead D. Y., Knitter G. H., Bensinger W., Strong D. M., Bernstein I. D. CD34+ marrow cells, devoid of T and B lymphocytes, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated allogeneic baboons. Blood 1992; 80: 1693–1701
   PubMed Web of Science ®Google Scholar
• Knapp W., Strobl H., Scheinecker C., Bello Fernandez C., Majdic O. Molecular characterization of CD34+ human hematopoietic progenitor cells. Annuls of Hematology 1995; 70: 281–296
   PubMed Web of Science ®Google Scholar
• Körbling M., Hub Y. O., Durett A., Mirza N., Miller P., Engel H., Anderlini P., Van Besien K., Andreeff M., Przepiorka D., Deisseroth A. B., Champlin R. E. Allogeneic blood stem cell transplantation: Peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-ldlm) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 1995; 86: 2842–2848
   PubMed Web of Science ®Google Scholar
• Link H., Arseniev L., BÄRe O., Berenson R. J., Battmer K., Kadar J., Jacobs R., Casper J., KÜHl J., Schubert J., Diedrich H., Poliwoda H. Combined transplantation of allogeneic bone marrow and CD34+ blood cells. Blood 1995; 86: 2500–2508
   PubMed Web of Science ®Google Scholar
• Grigg A. P., Roberts A. W., Raunow H., Houghton S., Layton J. E., Boyd A. W., McGrath K. M., Maher D. Optimizing dose and scheduling of filgrastim (granu-locyte colony-stimulating factor) for mobilization and collection of peripheral blood progenitor cells in normal volunteers. Blood 1995; 86: 4437–4445
   PubMed Web of Science ®Google Scholar
• Link H., Arseniev L., BÄHre O., Kadar J., Diedrich H., Poliwoda H. Transplantation of allogeneic CD34+ blood cells. Blood 1996; 87: 4903–4909
   PubMed Web of Science ®Google Scholar
• Berenson R. J., Bensinger W. I., Hill R. S., Andrews R. G., Garcia-Lopez J., Kalamasz D. F., Still B. J., Spitzer G., Buckner C. D., Bernstein I. D., Thomas E. D. Engraftment after infusion of CD34+ marrow cells in patients with breast cancer or neuroblastoma. Blood 1991; 77: 1717–1722
   PubMed Web of Science ®Google Scholar
• Dunbar C., Cottler-Fox M., Shaugnessy J. A., Doren S., Carter C., Berenson R., Brown S., Moen R. C., Greenblatt J., Stewart F. M., Leitman S., Wyndham W. H., Cowan K., Young N. S., Nienhuis N. S. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long term engraftment after autologous transplantation. Blood 1995; 85: 3048–3057
   PubMed Web of Science ®Google Scholar
• Brugger W., Henschler R., Heimfeld S., Berenson R. J., Mertelsmann R., Kanz L. Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epimbicin. Blood 1994; 84: 1421–1426
   PubMed Web of Science ®Google Scholar
• Negrin R. S., Kusnierz-Glaz C. R., Still B. J., Schriber J. R., Chao N. J., Long G. D., Hoyle C., Hu W. W., Homing S. J., Brown B. W., Blume K. G., Strober S. Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma. Blood 1995; 85: 3334–3341
   PubMed Web of Science ®Google Scholar
• Gazitt Y., Reading C. C., Hoffman R., Wickrerna A., Vesole D. H., Jagannath S., Condino J., Lee B., Barlogie B., Tricot G. Purified CD34+ Lin- Thy+ stem cells do not contain clonal myeloma cells. Blood 1995; 86: 381–389
   PubMed Web of Science ®Google Scholar
• Shpall E. J., Jones R. B., Bearman S. I., Franklin W. A., Archer P. G., Curiel T., Bitter M., Claman H. N., Stemmer S. M., Purdy M., et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-posi-tive peripheral-blood progenitors and growth factors on engraftment. Journal of Clinical Oncology 1994; 12: 28–36
   PubMed Web of Science ®Google Scholar
• Rill D. R., Santana V. M., Roberts W. M., Nilson T., Bowman L. C., Krance R. A., Heslop H. E., Moen R. C., Me J. N., Brenner M. K. Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 1994; 84: 380–383
   PubMed Web of Science ®Google Scholar
• Schmitz N., Dreger P., Suttorp M., Rohwedder E. B., Haferlach T., LÖFfler H., Hunter A., Russell N. H. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony stimulating factor). Blood 1995; 85: 1666–1672
   PubMed Web of Science ®Google Scholar
• Körbling M., Przepiorka D., Van Besien K., Giralt S., Andersson B., Huh Y. O., Kleine H. D., Seong D., Deisseroth A. B., Andreeff M., Champlin R. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 1995; 85: 1659–1665
   PubMed Web of Science ®Google Scholar
• Bensinger W. I., Weaver C. H., Appelbaum F. R., Rowley S., Demirer T., Sanders J., Storb R., Buckner C. D. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor. Blood 1995; 85: 1655–1658
   PubMed Web of Science ®Google Scholar
• Schmitz N., Bacigalupo A., Labopin M., Majolino I., Laporte J. P., Brinch L., Cook G., Lambertenghi-Deliliers G., Lange A., Rozman C., Garcia-Conde J., Finke J., Domingo-Albos A., Gratwohl A. Transplantation of allogeneic peripheral blood progenitor cells—the EBMT experience. Bone Marrow Transplant 1996; 17, Suppl. 2, S40-S46.
   PubMedGoogle Scholar
• Goulmy E., Schipper R., Pool J., Blokland E., Falkenburg J. H. F., Vosseu J., Gratwohl A., Vogelsang G. B., Van Houwelingen H. C., Van Rood J. J. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. New England Journal of Medicine 1996; 334: 281–285
   PubMed Web of Science ®Google Scholar
• Kernan N. A., Dupont B. Minor histocompatibility antigens and marrow transplantation. New England Journal of Medicine 1996; 334: 323–324
   PubMed Web of Science ®Google Scholar
• Ferrara J. L., Deeg H. J. Graft-versus-host disease. New England Journal of Medicine 1991; 324: 667–674
   PubMed Web of Science ®Google Scholar
• Vogelsang G. B., Hess A. D. Graft-versus-host disease: New directions for a persistent problem. Blood 1994; 84: 2061–2067
   PubMed Web of Science ®Google Scholar
• Verdonck L. F., De Gast G. C., Van Heugten H. G., Dekker A. W. A fixed low number of T cells in HLA-identical allogeneic bone marrow transplantation. Blood 1990; 75: 776–780
   PubMed Web of Science ®Google Scholar
• Kernan N. A., Collins N. H., Juliano L., Cartagena T., Dupont B., O'Reilly R. J. Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease. Blood 1986; 68: 770–773
   PubMed Web of Science ®Google Scholar
• Wagner J. E., Santos G. W., Noga S. J., Rowley S. D., Davis J., Vogelsang G. B., Farmer E. R., Zehnbauer B. A., Saral R., Donnenberg A. D. Bone marrow graft engineering by counterflow centrifugal elutriation: results of a phase I-II clinical trial. Blood 1990; 75: 1370–1377
   PubMed Web of Science ®Google Scholar
• Theobald M., Nierle T., Bunjes D., Arnold R., Heimpel H. Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. New England Journal of Medicine 1992; 327: 1613–1617
   PubMed Web of Science ®Google Scholar
• Schwarer A. P., Jiang Y. Z., Brookes P. A., Barrett A. J., Batchelor J. R., Goldman J. M., Lechler R. I. Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantation. Lancet 1993; 341: 203–205
   PubMed Web of Science ®Google Scholar
• Pan L., Delmonte J., Jr., Jalonen C. K., Ferrara J. L. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 1995; 86: 4422–4429
   PubMed Web of Science ®Google Scholar
• Storb R., Prentice R. L., Sullivan K. M., Shulman H., Deeg H. J., Doney K. C., Buckner C. D., Clift R. A., Witherspoon R. P., Appelbaum F. R., Sanders J. E., Stewart P., Thomas E. D. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med 1983; 98: 461–465
   PubMed Web of Science ®Google Scholar
• Sullivan K. M., Storb R., Buckner C. D., Fefer A., Fisher L., Weiden P. L., Witherspoon R. P., Appelbaum F. R., Banaji M., Hansen J., Martin P., Sanders J. E., Singer J., Thomas E. D. Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms. New England Journal of Medicine 1989; 320: 828–834
   PubMed Web of Science ®Google Scholar
• Kolb H. J., Schattenberg A., Goldman J. M., Hertenstein B., Jacobsen N., Arcese W., Ljungman P., Ferrant A., Verdonck L., Niederwieser D., Van Rhee F., Mittermueller J., De Witte T., Holler E., Ansari H. Graft versus leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041–2050, for thr European Group of Blood and Bone Marrow Transplantation and Working Party Chronic Leukemia.
   PubMed Web of Science ®Google Scholar
• Apperley J. F., Mauro F. R., Goldman J. M., Gregory W., Arthur C. K., Hows J., Arcese W., Papa G., Mandelli F., Wardle D., Gravett P., Franklin I. M., Bandini G., Ricci P., Tura S., Iacone A., Torlontano G., Heit W., Champlin R., Gale R. P. Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect. British Journal of Haematology 1988; 69: 239–245
   PubMed Web of Science ®Google Scholar
• Goldman J. M., Gale R. P., Horowitz M. M., Biggs J. C., Champlin R. E., Gluckman E., Hoffmann R. G., Jacobsen S. J., Marmont A. M., McGlave P. B., Messner H. A., Rimm A. A., Rozman C., Speck B., Tura S., Weiner R. S., Bortin M. M. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: Increased risk for relapse associated with T-cell depletion. Ann Intern Med 1988; 108: 806–814
   PubMed Web of Science ®Google Scholar
• Horowitz M. M., Gale R. P., Sondel P. M., Goldman J. M., Kersey J., Kolb H.-J., Rimm A. A., RingdÉN O., Rozman C., Speck B., Truitt R. L., Zwaan F. E., Bortin M. M. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555–562
   PubMed Web of Science ®Google Scholar
• Marmont A. M., Horowitz M. M., Gale R. P., Sobocinski K., Ash R. C., Van Bekkum D. W., Champlin R. E., Dicke K. A., Goldman J. M., Good R. A., Herzig R. H., Hong R., Masaoka T., Rinim A. A., Ringden O., Speck B., Weiner R. S., Bortin M. M. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120–2130
   PubMed Web of Science ®Google Scholar
• Verdonck L. F., Dekker A. W., De Gast G. C., Van Kempen M. L., Lokhorst H. M., Nieuwenhuis H. K. Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft. Blood 1994; 83: 3090–3096
   PubMed Web of Science ®Google Scholar
• Palathumpat V., Dejbakhsh Jones S., Holm B., Wang H., Liang O., Strober S. Studies of CD4-CD8-alpha beta bone marrow T cells with suppressor activity. Journal of Immunology 1992; 148: 373–380
   PubMed Web of Science ®Google Scholar
• Negrin R. S., Kusnierz-Glaz C., Blume K. G., Stroher S. Enrichment of allogeneic CD34+ cells and T cell depletion by percoll density gradient centrifugation. Bone Marrow Transplant 1996; 17: S31–S33
   PubMed Web of Science ®Google Scholar
• Przepiorka D., Ippoliti C., Panina A., Goodrich J., Giralt S., Van Besien K., Mehra R., Deisseroth A. B., Andersson B., Luna M., et al. Ganciclovir three times per week is not adequate to prevent cytomegalovirus reactivation after T cell-depleted marrow transplantation. Bone Marrow Transplant 1994; 13: 461–464
   PubMed Web of Science ®Google Scholar
• Maraninchi D., Blaise D., Rio B., Leblond V., Dreyfus F., Gluckman E., Guyotat D., Pico J. L., Michallet M., Ifrah N. Impact of T-cell depletion on outcome of allogeneic bone marrow transplantation for standard-risk leukaemias. Lancet 1987; 11: 175–178
   Google Scholar
• Martin P. J. The role of donor lymphoid cells in allogeneic marrow engraftment. Bone Marrow Transplant 1990; 6: 283–289
   PubMed Web of Science ®Google Scholar
• Papadopoulos E. B., Ladanyi M., Emanuel D., Mackinnon S., Boulad F., Carabasi M. H., Castro Malaspina H., Childs B. H., Gillio A. P., Small T. N., Young J. W., Kernan N. A., O'Reilly R. J. Infusions of donor leukocytes to treat Epstein-Barr virus- associated lymphoproliferative disorders after allogeneic bone marrow transplantation. New England Journal of Medicine 1994; 330: 1185–1191
   PubMed Web of Science ®Google Scholar
• Corringham R. E. T., Ho A. D. Rapid and sustained allogeneic transplantation using immunoselected CD34+ selected peripheral blood progenitor cells mobilized by recombinant granulocyte- and granulocyte-macrophage colony stimulating factors. Blood 1995; 86: 2052–2054
   PubMedGoogle Scholar
• Williams S. F., Lee W. J., Bender J. G., Zimmerman T., Swinney P., Blake M., Carreon J., Schilling M., Smith S., Williams D. E., Oldham F., Van Epps D. Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer. Blood 1996; 87: 1687–1691
   PubMed Web of Science ®Google Scholar
• Brugger W., Heimfeld S., Berenson R. J., Mertelsmann R., Kanz L. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. New England Journal of Medicine 1995; 333: 283–287
   PubMed Web of Science ®Google Scholar
• Arseniev L., Tischler H.-J., Battmer K., SÜDmeyer I., Casper J., Link H. Treatment of poor marrow graft function with enriched allogeneic CD34+ cells immunoselected from G-CSF mobilized peripheral blood progenitor cells of the marrow donor. Bone Marrow Transplant 1994; 14: 791–797
   PubMed Web of Science ®Google Scholar
• Weaver C. H., Buckner C. D., Longin K., Appelbaum F. R., Rowley S., Lilleby K., Miser J., Storb R., Hansen J. A., Bensinger W. Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor. Blood 1993; 82: 1981–1984
   PubMed Web of Science ®Google Scholar
• Link H., Boogaerts M., Fauser A. A., Slavin S., Reiffers J., Gorin N. C., Carella A. M., Mandelli F., Burdach S., Ferrant A., Linkesch W., Tura S., Bacigalupo A., Schindel F., Heinrichs H. A controlled trial of recombinant human erythropoietin after bone marrow transplantation. Blood 1994; 84: 3327–3335
   PubMed Web of Science ®Google Scholar
• Arseniev L., Battmer K., Stucki A., SÜDmeier I., Kadar J. G., Martin M., Link H. Ex-vivo- Vermehrung von hamatopoetischen Progenitorzellen für die klinische Anwendung. Med Klin 1996; 91: 50–59, Sondernr. 3
   Google Scholar
• Arseniev L., Link H., HÜBner G., Novotny Y., Ganser A., Hertenstein B. Transient increase of residual host leukocytes immediately after transplantation of expanded and nonex-panded allogenetic CD34+ blood cell is of host origin. Blood 1997, in press.
   PubMedGoogle Scholar
• Ferrara J., Lipton J., Hellman S., Burakoff S., Mauch P. Engraftment following T-cell depleted marrow transplantation: I. The role of major and minor histocompatibility barriers. Transplantation 1987; 43: 461–467
   PubMed Web of Science ®Google Scholar
• Aversa F., Tabilio A., Terenzi A., Velardi A., Falzetti F., Giannoni G., Iacucci R., Zei T., Martelli M. P., Gambelunghe C., Rossetti M., Caputo G., Latini P., Aristei C., Raymondi C., Reisner Y., Martelli M. F. Successful engraftment of T-cell-depleted haploidentical “three-loci” incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony stimulating factor—mobilized peripheral blood progenitor cells to bone marrow inoculum. Blood 1994; 84: 3948–3955
   PubMed Web of Science ®Google Scholar
• Kaufman C. L., Colson Y. L., Wren S. M., Watkins S., Simmons R. L., Ildstad S. T. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 1994; 84: 2436–2446
   PubMed Web of Science ®Google Scholar
• Uharek L., Gassmau W., Glass B., Steinmann J., Loeffler H., Mueller Ruchholtz W. Influence of cell dose and graft-versus-host reactivity on rejection rates after allogeneic bone marrow transplantation. Blood 1992; 79: 1612–1621
   PubMed Web of Science ®Google Scholar
• Bachar-Lustig E., Rachamim N., Li H. W., Lan F., Reisner Y. Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nat Med 1995; 1: 1268–1273
   PubMed Web of Science ®Google Scholar
• Friedrich W., MÜLler S., Schreiner T., Wiesneth M. Purified CD34+ blood stem cells from HLA-hap-loidentical parental donors for transplantation in SCID. Bone Marrow Transplantation 1996; 17, S112, A494 (Abstract)
   PubMedGoogle Scholar
• Stockschläder M., LÖLiger C., KrÜGer W., Zeller W., Heyll A., SchÖNrock-Nabulsi P., Zander A. Transplantation of allogeneic rhG-CSF mobilized peripheral CD34+ cells from an HLA-identical unrelated donor. Bone Marrow Transplant 1995; 16: 719–722
   PubMed Web of Science ®Google Scholar
• Arseniev L., Goudeva L., Battmer K., Stucki A., SÜDmeier I., Pappe I., Kadar J. G., Martin M., Ganser A., Link H. G-CSF and leukapheresis induced changes in the circulating CD34+ cell in healthy sibling donors. British Journal of Haematology 1996; 93: 275, A1038 (Abstract).
   Google Scholar
• Johnson B. D., Drobyski W. R., Truitt R. L. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. Bone Marrow Transplant 1993; 11: 329–336
   PubMed Web of Science ®Google Scholar
• Mackinnon S., Papadopoulos E. B., Carabasi M. H., Reich L., Collins N. H., Boulad F., Castro-Malaspina H., Childs B. H., Gillio A. P., Kernan N. A., Small T. N., Young J. W., O'Reilly R. J. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: Separation of graft-versus-leukemia responses from graft-versus-host disease. Blood 1995; 86: 1261–1268
   PubMed Web of Science ®Google Scholar
• Hornung R. L., Longo D. L., Bowersox O. C., Kwak L. W. Tumor antigen-specific immunization of bone marrow transplantation donors as adoptive therapy against established tumor. Journal of the National Cancer Institute 1995; 87: 1289–1296
   PubMed Web of Science ®Google Scholar
• Kwak L. W., Taub D. D., Duffey P. L., Bensinger W. I., Bryant E. M., Reynolds C. W., Longo D. L. Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor. Lancet 1995; 345: 1016–1020
   PubMed Web of Science ®Google Scholar
• Walter E., Greenberg P. D., Gilbert M. J., Finch R. J., Watanabe K., Thomas E. D., Riddell S. R. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. New England Journal of Medicine 1995; 333: 1038–1044
   PubMed Web of Science ®Google Scholar
• Rooney C. M., Smith C. A., Ng C. Y., Loftin S., Li C., Krance R. A., Brenner M. K., Heslop H. E. Use of gene-modified virus-specific T lymphocytes to control Epstein-Bar-virus-related lymphoproliferation. Lancet 1995; 345: 9–13
   PubMed Web of Science ®Google Scholar
• Caux C., Massacrier C., Dezutter-Dambuyant C., Vanbervliet B., Jacquet C., Schmitt D., Banchereau J. Human dendritic Langerhans cells generated in vitro from CD34+ progenitors can prime naive CD4+ T cells and process soluble antigen. Journal of Immunology 1995; 155: 5427–5435
   PubMed Web of Science ®Google Scholar
• Holland H. K., Bray A. M., Geller R. B., Devine S. M., McCollum J., Connaghan D. G., Fleming W. H., Heffner L. T., Hillyer C., Waller E. K., Winton E. F., Wingard J. R. Transplantation of HLA-identical positively selected CD34+ cells of peripheral blood (PBSC) and marrow (BM) from related donors results in prompt engraftment and low incidence of GVHD in recipients undergoing allogeneic transplantation. Blood 1995; 86: 389a, A1543 (Abstract)
   Google Scholar
• Stockschläder M., Hassan H. T., Zeller W., KrÜGer W., Clausen J., LÖLiger C., Tom Dieck A., KrÖGer N., Link H., Kahisch H., Hossfeld D. K., Zander A. Allogeneic transplantation with CD34+ selected cells. Leuk Lymph 1996, In Press)
   Web of Science ®Google Scholar
• Urbano-ispizua A., Rozman Martinez C., Marin P., BrÌOnes J., Rovira M., Feliz P., Viguna M. C., Merino A., Sierra J., Mazzara R., Carreras E., Montserrat E. Rapid engraftment and low treatment related mortality after allogeneic transplantation using CD34+ selected cells from peripheral blood submitted. 1996; 1997
   Google Scholar
• Finke J., Brugger W., Bertz H., Einsele H., Behringer D., Kanz L., Mertelsmann R. Allogeneic transplantation of peripheral blood derived CD34+ selected progenitor cells from matched related donors: Results of a clinical phase I/II study. Blood 1995; 86: 290a, A1148 (Abstract)
   Google Scholar
• Bensinger W. I., Buckner C. D., Shannon-Dorcy K., Rowley S., Appelbaum I. R., Benyunes M., Clift R., Martin P., Demirer T., Storb R., Lee M., Schiller G. Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy. Blood 1996; 88: 4132–4138
   PubMed Web of Science ®Google Scholar
• Bacigalupo A., Mordini N., Pitto A., Piaggio G., Podesta M. CD34+ selected stem cell transplants in patients with advanced leukemia from 3 loci mismatched family donors. Blood 1995; 86: 937a, A3736 (Abstract)
   Google Scholar
• Müller S., Reiss U., Schreiner T., Wiesneth M., Friedrich W. Combined use of CD34+ blood stem cells and bone marrow for HLA nonidentical transplantation in children with leukaemia. Blood 1995; 86: 92a, A354 (Abstract)
   Google Scholar
• Yeager A. M., Holland H. K., Mogul M. J., Forte K., Lauer M., Boyer M. W., Turner C. W., Vega R. A., Beatty P. G., Jacobs C. A., Benyunes M. C., Wingard J. R. Transplantation of positively selected CD34+ cells from hap-loidentical parental donors for relapsed acute leukemia in children. Blood 1995; 86, Suppl. l, 291a (Abstract)
   Google Scholar